Skip to content
2000
Volume 4, Issue 3
  • ISSN: 1574-8928
  • E-ISSN: 2212-3970

Abstract

DNA topoisomerase is one of drug targets in cancer therapy. Camptothecin is a plant alkaloid derived from the Chinese tree Camptotheca acuminate. It has been demonstrated that the plant alkaloid camptothecin (CPT) caused DNA damage by specifically targeting DNA topoisomerase, effectively devastating a broad spectrum of tumors. Although the anti-tumoral activity of CPT has been intensively studies for nearly fifty years, recent advances in drug delivery systems of CPT have considerably improved this drug's efficiency. In this review, we will summarize the current status of CPTderived anti-cancer drugs in literatures and patents and highlight their clinical application.

Loading

Article metrics loading...

/content/journals/pra/10.2174/157489209789206913
2009-11-01
2025-09-21
Loading full text...

Full text loading...

/content/journals/pra/10.2174/157489209789206913
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test